MedTrace Logo

The Influence of Body Mass Index and Smartphone Overuse on Cervical Myofascial Pain: A Cross-sectional Study

NCT06221085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2024-06-21

No results posted yet for this study

Summary

An observational cross-sectional study will be conducted on 90 female students (right dominant) aged 19-26 years at Jazan University, they will have 40 points or more on Smartphone Addiction Proneness Scale (SAPS) and will be divided into three groups (30 students for each): Group I (BMI\<25kg/m2), Group II (BMI 25-30kg/m2), and Group III (BMI \>30 kg/m2). Pain pressure thresholds were measured using a pressure gauge algometer (PGA) over trigger points in the neck muscles.

Conditions

  • Cervical Myofascial Pain Syndrome
  • Smartphone Addiction
  • Body Weight
  • Obesity

Interventions

DIAGNOSTIC_TEST

Pain Pressure Threshold (PPT)

Researchers measure pain pressure thresholds (PPTs) by applying a Pressure gauge algometer (PGA) over the myofascial trigger points (TrPs) on the body. PPT is defined as the lowest stimulus intensity at which a subject perceives pain. The clinician applies it perpendicular to the long axis of the structure on which it is placed. The examiner increases the pressure at a rate of 1 kg/s until the subject feels pain or discomfort, and then the PPT values are measured three times for each muscle. Participants verbally report the first sensation of pain or discomfort, at which point the examiner stops the pressure.

Sponsors & Collaborators

  • University of Jazan

    lead OTHER_GOV

Principal Investigators

  • Mohamed M. Ahmed, PHD · University of Jazan

Eligibility

Min Age
19 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-18
Primary Completion
2024-04-15
Completion
2024-04-29

Countries

  • Saudi Arabia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06221085 on ClinicalTrials.gov